Proparacaine Hydrochloride 0.5 % as a sole topical anesthetic agent in primary pterygium surgery with autologous conjunctival graft: Our experience at tertiary care center,Vadodara

Journal Title: International Journal Of Research In Medicine - Year 2019, Vol 8, Issue 1

Abstract

BACKGROUND AND OBJECTIVES: This study aims to evaluate efficiency of Proparacaine Hydrochloride 0.5% as a sole anesthetic agent in primary pterygium excision surgery with glue free conjunctional autograft at tertiary care center in Vadodara. METHODS: A prospective, non-randomized interventional study comprising 42 patents (42 eyes) having primary pterygium was conducted at tertiary care center in Vadodara, Gujarat.Pterygium excision with glue free autologous conjunctival grafting done under 0.5% proparacaine (Paracaine) eyedrops.The visual analogue scale (VAS) was utilized to record intra and post-operative pain score. Patient’s comfort, intra and post operative painperceived by patients, supplementalanesthesia, complications and surgeon’s comfort noted. Anesthetist also noted vital parameters and any intravenous drugs required. RESULTS: No difference between intra and post-operative pain score (P=0.37) was observed in patients. The average surgical time from was 24.05 ± 2.05 minutes. 1 score was observed in 28 patents (66.66%). The average surgeon’s discomfort score was 1.45 ± 0.59. CONCLUSION: Primary thin atrophic pterygium surgery with autologous conjunctival graft can be performed successfully using 0.5% proparacaine Hydrochloride eyedrops. The ease of application, lack of ocular surface toxicity and sufficient anesthetic effect to complete the surgery make it an efficient & alternative modality to injectable anesthesia

Authors and Affiliations

Aparna Kekan Suhani S. Nayak

Keywords

Related Articles

Complete title of the manuscript: Efficacy and Safety of Resveratrol as an Adjuvant Therapy in Type 2 Diabetes Mellitus Patients: Result of a Randomized Active Controlled Clinical Study

BACKGROUND: No long term clinical efficacy and safety study of resveratrol as adjuvant therapy along with gold standard therapy has been conducted in type 2 diabetes mellitus (T2DM). The aim of this study was to investig...

An u nusual case r eport of primary non hodgkin’s lymphoma of mandible

BACKGROUND: Mandible accounts for 0.6% for isolated Primary Non Hodgkin’s lymphoma (PNHL). HIV associated PNHL presents with advanced disease and extra nodal involvement in up to 90% of patients. In the mandible main s...

Thyroid Cytology Evaluation By Bethesda System A Two Year Prospective Study

BACKGROUND: Thyroid lesions are one of the common conditions encountered in clinical practice. It is difficult to clinical evaluation & reach to correct diagnosis. Hence it is essential that a correct diagnosis is made a...

Evaluation of Anti-A and Anti-B Alloisogglutinin Titer in Group O Plateletpheresis Donors

BACKGROUND: Platelet (PLT) transfusions need to take into account the issues that arise due to significant amounts of ABO antigen being present on the platelets surface and anti-ABO alloisogglutinins being present in the...

Root canal morphology of mandibular first premolars in western Indian population: an in vitro study

BACKGROUND: To determine the root canal morphology of extracted mandibular first premolar teeth in Western Indian population using a decalcification and clearing technique. METHODOLOGY: Two hundred extracted human mandib...

Download PDF file
  • EP ID EP553293
  • DOI -
  • Views 87
  • Downloads 0

How To Cite

Aparna Kekan Suhani S. Nayak (2019). Proparacaine Hydrochloride 0.5 % as a sole topical anesthetic agent in primary pterygium surgery with autologous conjunctival graft: Our experience at tertiary care center,Vadodara. International Journal Of Research In Medicine, 8(1), 1-6. https://europub.co.uk/articles/-A-553293